Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

<p style="text-align:justify;"> To improve strategies for the treatment of BRAF-mutant advanced colorectal cancer (aCRC) patients, we examined individual data from patients treated with chemotherapy alone in three randomised trials to identify points on the treatment pathway where o...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Seligmann, JF, Fisher, D, Smith, CG, Richman, SD, Elliott, F, Brown, S, Adams, R, Maughan, T, Quirke, P, Cheadle, J, Seymour, M, Middleton, G
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Oxford University Press 2016

Ижил төстэй зүйлс

2530
-н: Bernadette McKinney
Хэвлэсэн: (2017-09-01)

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
-н: Adams, R, зэрэг
Хэвлэсэн: (2017)

BRAF and NRAS locus-specific variants have different outcomes on survival to colorectal cancer
-н: Summers, MG, зэрэг
Хэвлэсэн: (2016)

FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS and NRAS
-н: Adams, R, зэрэг
Хэвлэсэн: (2016)

Targeting mutant BRAF in colorectal cancer
-н: Carroll David, зэрэг
Хэвлэсэн: (2013-01-01)

Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
-н: Seymour, M, зэрэг
Хэвлэсэн: (2011)

The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer
-н: Forsythe, N, зэрэг
Хэвлэсэн: (2018)

Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing
-н: Susan D. Richman, зэрэг
Хэвлэсэн: (2011-01-01)

BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy
-н: Vinay K. Pattalachinti, зэрэг
Хэвлэсэн: (2025-02-01)

Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT
-н: Louise C Brown, зэрэг
Хэвлэсэн: (2022-12-01)

Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models
-н: Federica Maione, зэрэг
Хэвлэсэн: (2024-06-01)

Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.
-н: Catherine E Bond, зэрэг
Хэвлэсэн: (2012-01-01)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
-н: Elisa Grassi, зэрэг
Хэвлэсэн: (2021-06-01)

Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
-н: Maughan, T, зэрэг
Хэвлэсэн: (2009)

BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
-н: Yasar Subutay Peker, зэрэг
Хэвлэсэн: (2018-01-01)

DEFICIENT MISMATCH REPAIR (DMMR) AND BRAF MUTATION (MT) STATUS IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC): A META-ANALYSIS OF THE CAIRO, CAIRO2, COIN AND FOCUS STUDIES
-н: Venderbosch, S, зэрэг
Хэвлэсэн: (2012)

Ciclosporin in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer - Results of PICCOLO, a Large Randomised Trial With Prospective Molecular Stratification
-н: Middleton, G, зэрэг
Хэвлэсэн: (2011)

Pipeline electrical and instrumentation : switches and transmitters (CT25.30. and 31)
-н: 599270 National Center for Construction Education and Research
Хэвлэсэн: (2002)

Design of Collection Module of Underground Personnel Information Based on CC2530
-н: ZHENG Mao-quan, зэрэг
Хэвлэсэн: (2012-06-01)

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.
-н: Seymour, M, зэрэг
Хэвлэсэн: (2013)

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): A prospectively stratified randomised trial
-н: Seymour, M, зэрэг
Хэвлэсэн: (2013)

Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia
-н: M. Yu. Fedyanin, зэрэг
Хэвлэсэн: (2021-06-01)

Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors
-н: Ting Xu, зэрэг
Хэвлэсэн: (2022-06-01)

Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
-н: Ting Xu, зэрэг
Хэвлэсэн: (2023-05-01)

Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.
-н: Smith, C, зэрэг
Хэвлэсэн: (2013)

Design of Mine-used Wireless Roof Pressure Sensor Based on CC2530
-н: WU Yao-ming, зэрэг
Хэвлэсэн: (2012-12-01)

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
-н: Maughan, T, зэрэг
Хэвлэсэн: (2010)

RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer
-н: Peipei Shang, зэрэг
Хэвлэсэн: (2023-06-01)

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
-н: Evelina Miele, зэрэг
Хэвлэсэн: (2020-02-01)

Braf-Mutant Melanomas: Biology and Therapy
-н: Elvira Pelosi, зэрэг
Хэвлэсэн: (2024-12-01)

Dabrafenib for treatment of BRAF-mutant melanoma
-н: Kainthla R, зэрэг
Хэвлэсэн: (2013-12-01)

2530 Relationship between preexisting pain and completion of a community-based wellness program
-н: Chantay Young, зэрэг
Хэвлэсэн: (2018-06-01)

SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.
-н: Ida V Lundberg, зэрэг
Хэвлэсэн: (2014-01-01)

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer
-н: Pan JH, зэрэг
Хэвлэсэн: (2018-08-01)

Identification of anticancer drugs to radiosensitise <i>BRAF</i>-wild-type and mutant colorectal cancer
-н: Rebecca Carter, зэрэг
Хэвлэсэн: (2019-06-01)

THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
-н: Maughan, T, зэрэг
Хэвлэсэн: (2010)

Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.
-н: Wood, G, зэрэг
Хэвлэсэн: (2017)

Treatment with BRAF/MEK: inhibitors in mutant BRAF V600E papillary craniopharyngioma
-н: Eva Marie Erfurth, зэрэг
Хэвлэсэн: (2024-12-01)

Mutant-selective degradation by BRAF-targeting PROTACs
-н: Shanique Alabi, зэрэг
Хэвлэсэн: (2021-02-01)

Preoperative prediction of early recurrence in patients with BRAF mutant colorectal cancer using a intergrated nomogram
-н: Zhenbin Jin, зэрэг
Хэвлэсэн: (2024-10-01)